Empreendimentos Pague Menos SA

Empreendimentos Pague Menos SA maintains a debt-to-equity ratio of 1.2, indicating a moderate level of leverage, while its liquidity position is characterized as medium, with a current ratio of 1.59. The company's free cash flow of 349.4 million BRL supports its operational flexibility, although its net cash position is negative after accounting for total debt. In terms of profitability, the company's return on equity (ROE) is 8.44%, which is a measure of how effectively it generates profit from shareholders' equity. Its return on assets (ROA) is 2.62%, suggesting that the company is generating a relatively modest return on its total asset base. The company's revenue is concentrated in the drug retailing segment, with no disclosed geographic diversification. This concentration may expose the company to specific market risks, although the exact nature of these risks is not quantified in the available data. Looking at the growth trajectory, the company's revenue for the latest period is 14.9 billion BRL. While the outlook for the current and next fiscal years is not explicitly provided, the company's operating income of 861.17 million BRL and net income of 260.28 million BRL suggest a stable financial performance. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could affect its ability to meet short-term obligations without additional financing. Recent events, such as analyst estimates, show a mean price target of 7.24 BRL and a median price target of 7.99 BRL. The mean recommendation from analysts is 2.40, indicating a generally positive outlook, with four buy recommendations and no strong buy or hold recommendations.